|
Deadline Set to Withdraw Pending ANDAs, Avoid Backlog Fee
Generic-drug makers have until Sept. 28 to either withdraw pending ANDAs or face a backlog fee, the FDA says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
FDA Questions Reckitt’s Motives in Petition Denial, OKs Suboxone ANDAsFDA Questions Reckitt Benckiser’s Motives in Petition Denial, OKs Two Suboxone GenericsFDA: More Work May Be Needed to Discourage Anticompetitive PetitionsFDA Sets Higher Than Expected Fiscal 2013 Generic Facility Fees, Payment Due March 4
|
Subscribe
Archives